- Home
- BCTX vs TKLF Comparison
BCTX vs TKLF Comparison
Compare BCTX & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- TKLF
- Stock Information
- Founded
- BCTX 2014
- TKLF 2006
- Country
- BCTX Canada
- TKLF Japan
- Employees
- BCTX N/A
- TKLF N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- TKLF Other Specialty Stores
- Sector
- BCTX Health Care
- TKLF Consumer Discretionary
- Exchange
- BCTX Nasdaq
- TKLF Nasdaq
- Market Cap
- BCTX 15.8M
- TKLF 15.7M
- IPO Year
- BCTX N/A
- TKLF 2022
- Fundamental
- Price
- BCTX $3.85
- TKLF $2.86
- Analyst Decision
- BCTX Strong Buy
- TKLF
- Analyst Count
- BCTX 1
- TKLF 0
- Target Price
- BCTX $32.00
- TKLF N/A
- AVG Volume (30 Days)
- BCTX 45.7K
- TKLF 16.2K
- Earning Date
- BCTX 03-12-2025
- TKLF 12-18-2024
- Dividend Yield
- BCTX N/A
- TKLF N/A
- EPS Growth
- BCTX N/A
- TKLF N/A
- EPS
- BCTX N/A
- TKLF 1.70
- Revenue
- BCTX N/A
- TKLF $219,520,631.00
- Revenue This Year
- BCTX N/A
- TKLF N/A
- Revenue Next Year
- BCTX N/A
- TKLF N/A
- P/E Ratio
- BCTX N/A
- TKLF $1.77
- Revenue Growth
- BCTX N/A
- TKLF 32.02
- 52 Week Low
- BCTX $0.35
- TKLF $2.00
- 52 Week High
- BCTX $7.87
- TKLF $8.53
- Technical
- Relative Strength Index (RSI)
- BCTX 50.94
- TKLF 28.28
- Support Level
- BCTX $3.44
- TKLF $2.85
- Resistance Level
- BCTX $4.36
- TKLF $3.54
- Average True Range (ATR)
- BCTX 0.38
- TKLF 0.27
- MACD
- BCTX -0.05
- TKLF -0.04
- Stochastic Oscillator
- BCTX 35.42
- TKLF 6.13
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.